← RIGEL PHARMACEUTICALS INC

AMENDED AND RESTATED CREDIT, SECURITY AND GUARANTY AGREEMENT

Signed May 5, 2026

Committed
$40m
Matures
May 2031
TrancheSizeMaturesMargin
Revolving Loan Facility$40mMay 2031400 bps

Priced over Term SOFR (Revolving credit facility).

LevelConditionMarginUnused fee
Level Level 1all times400 bpsn/a
Tested springingHeadroom not yet measuredn/a

No source quote on file for this covenant.

Read the filing on sec.gov ↗
Tested otherHeadroom not yet measuredn/a

No source quote on file for this covenant.

Read the filing on sec.gov ↗

Download CSV · Download JSON

Amendments

  1. May 11, 2026

    Amendment

    Amendment No. 1 permits Rigel to enter into the Arvinas License Agreement and make Arvinas Payments, and adds related definitions. It also amends the Material Contracts list, expands Permitted Investments to include the Arvinas transaction, and revises Permitted Contingent Obligations to allow Arvinas Payments subject to no Specified Event of Default and covenant compliance.
    • definitions.arvinas_license_agreement: n/a → n/a §Section 2(a)
    • definitions.first_amendment: n/a → n/a §Section 2(b)
    • definitions.first_amendment_effective_date: n/a → 2026-05-11 §Section 2(c)
    • definition.material_contracts: n/a → n/a §Section 2(e)
    • definition.permitted_investments: n/a → n/a §Section 2(f)
    • definition.permitted_contingent_obligations: n/a → n/a §Section 2(g)
    Filing ↗
Report an error